Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buchner

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Plos Genetics|April 30, 2019
Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunctionDov Tiosano, Hagit N Baris, Anlu Chen, et al.
Der Urologe. Ausg. A|February 23, 2011
[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]M May, H-M Fritsche, C Gilfrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter studyJosef A Buchner, Florian Kofler, Lucas Etzel, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Der Urologe. Ausg. A|February 23, 2011
[Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]M May, M Burger, S Brookman-May, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Neuro-Oncology|May 30, 2024
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapyJosef A Buchner, Florian Kofler, Michael Mayinger, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
Improving risk assessment of local failure in brain metastases patients using vision transformers - A multicentric development and validation studyAyhan Can Erdur, Daniel Scholz, Q Mai Nguyen, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Plos Genetics|April 30, 2019
Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunctionDov Tiosano, Hagit N Baris, Anlu Chen, et al.
Der Urologe. Ausg. A|February 23, 2011
[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]M May, H-M Fritsche, C Gilfrich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter studyJosef A Buchner, Florian Kofler, Lucas Etzel, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Der Urologe. Ausg. A|February 23, 2011
[Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]M May, M Burger, S Brookman-May, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Neuro-Oncology|May 30, 2024
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapyJosef A Buchner, Florian Kofler, Michael Mayinger, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
Improving risk assessment of local failure in brain metastases patients using vision transformers - A multicentric development and validation studyAyhan Can Erdur, Daniel Scholz, Q Mai Nguyen, et al.
Pageof 28